ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Minocycline and Aspirin in the Treatment of Bipolar Depression

ClinicalTrials.gov ID: NCT01429272

Public ClinicalTrials.gov record NCT01429272. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 6:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01429272
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Laureate Institute for Brain Research, Inc.
Other
Enrollment
99 participants

Conditions and interventions

Interventions

  • Aspirin Drug
  • Minocycline Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Jul 31, 2015
Completion
Aug 31, 2015
Last update posted
Jan 10, 2018

2011 – 2015

United States locations

U.S. sites
3
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
University of Kansas Medical Center Research Institute Wichita Kansas 67207
University of Oklahoma Department of Psychiatry Tulsa Oklahoma 74135
Laureate Institute for Brain Research Tulsa Oklahoma 74136-3326

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01429272, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2018 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01429272 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →